Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
142
NMPA:142
Drug Approvals
Ropivacaine Hydrochloride Injection
- Product Name
- 盐酸罗哌卡因注射液
- Approval Number
- 国药准字H20254307
- Approval Date
- May 27, 2025
NMPA
Ropivacaine Hydrochloride Injection
- Product Name
- 盐酸罗哌卡因注射液
- Approval Number
- 国药准字H20254306
- Approval Date
- May 27, 2025
NMPA
Nimodipine Oral Solution
- Product Name
- 尼莫地平口服溶液
- Approval Number
- 国药准字H20253866
- Approval Date
- Apr 15, 2025
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20253383
- Approval Date
- Feb 20, 2025
NMPA
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20249220
- Approval Date
- Oct 29, 2024
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20243279
- Approval Date
- Feb 23, 2024
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20243280
- Approval Date
- Feb 23, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
Clinical Trials
No trials found
News
No news found